- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.3: 4 residues within 4Å:- Chain D: L.515
- Ligands: POV.5, POV.38, POV.39
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.515
PCW.18: 4 residues within 4Å:- Chain A: L.515
- Ligands: POV.9, POV.10, POV.20
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.515
PCW.30: 4 residues within 4Å:- Chain B: L.515
- Ligands: POV.24, POV.25, POV.32
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.515
PCW.44: 4 residues within 4Å:- Chain C: L.515
- Ligands: POV.36, POV.37, POV.46
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.515
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 8 residues within 4Å:- Chain A: M.475, V.478, M.482, S.488, G.489, V.492
- Ligands: POV.6, POV.15
Ligand excluded by PLIPPOV.5: 18 residues within 4Å:- Chain A: W.535, A.538, V.539, L.542, Y.549, Q.553, D.565, Y.566, P.567, L.570
- Chain D: I.381, T.384, M.385, I.388, Y.389
- Ligands: PCW.3, POV.38, POV.39
Ligand excluded by PLIPPOV.6: 13 residues within 4Å:- Chain A: P.464, L.468, T.471, Q.523, K.524, I.526, F.527, G.528, R.624
- Chain B: I.604
- Ligands: Y01.2, POV.4, POV.15
Ligand excluded by PLIPPOV.7: 14 residues within 4Å:- Chain A: F.383, C.386, C.387, L.413, L.426, E.429, T.432, V.433, V.476, T.479, M.480, R.483, L.484, M.494
Ligand excluded by PLIPPOV.8: 3 residues within 4Å:- Chain A: F.474, V.478, M.482
Ligand excluded by PLIPPOV.9: 19 residues within 4Å:- Chain A: R.366, C.370, G.373, A.374, L.377, L.378, V.505, M.506, F.508, G.511, F.512, Q.513, M.514, L.515
- Chain B: W.535, L.536, V.539
- Ligands: PCW.18, POV.20
Ligand excluded by PLIPPOV.10: 11 residues within 4Å:- Chain A: L.378, C.382, M.385, Y.389, K.421, I.424, R.425, G.428
- Ligands: Y01.1, PCW.18, POV.20
Ligand excluded by PLIPPOV.12: 9 residues within 4Å:- Chain A: P.592, F.593, I.597
- Chain D: F.496, M.531
- Ligands: Y01.11, Y01.43, POV.45, POV.47
Ligand excluded by PLIPPOV.15: 8 residues within 4Å:- Chain A: F.496, M.531
- Chain B: P.592, F.593, I.597
- Ligands: POV.4, POV.6, Y01.14
Ligand excluded by PLIPPOV.19: 7 residues within 4Å:- Chain B: M.475, V.478, M.482, S.488, V.492
- Ligands: POV.21, POV.27
Ligand excluded by PLIPPOV.20: 18 residues within 4Å:- Chain A: I.381, T.384, M.385, I.388, Y.389
- Chain B: W.535, A.538, V.539, L.542, Y.549, Q.553, D.565, Y.566, P.567, L.570
- Ligands: POV.9, POV.10, PCW.18
Ligand excluded by PLIPPOV.21: 14 residues within 4Å:- Chain B: P.464, L.468, T.471, F.496, Q.523, K.524, I.526, F.527, G.528, R.624
- Chain C: I.604
- Ligands: Y01.17, POV.19, POV.27
Ligand excluded by PLIPPOV.22: 14 residues within 4Å:- Chain B: F.383, C.386, C.387, L.413, Y.417, L.426, E.429, T.432, V.476, T.479, M.480, R.483, L.484, M.494
Ligand excluded by PLIPPOV.23: 3 residues within 4Å:- Chain B: F.474, V.478, M.482
Ligand excluded by PLIPPOV.24: 19 residues within 4Å:- Chain B: R.366, C.370, G.373, A.374, L.377, L.378, V.505, M.506, F.508, G.511, F.512, Q.513, M.514, L.515
- Chain C: W.535, L.536, V.539
- Ligands: PCW.30, POV.32
Ligand excluded by PLIPPOV.25: 11 residues within 4Å:- Chain B: L.378, C.382, M.385, Y.389, K.421, I.424, R.425, G.428
- Ligands: Y01.16, PCW.30, POV.32
Ligand excluded by PLIPPOV.27: 9 residues within 4Å:- Chain B: F.496, M.531
- Chain C: P.592, F.593, I.597
- Ligands: Y01.17, POV.19, POV.21, Y01.26
Ligand excluded by PLIPPOV.31: 7 residues within 4Å:- Chain C: M.475, M.482, S.488, G.489, V.492
- Ligands: POV.33, POV.41
Ligand excluded by PLIPPOV.32: 18 residues within 4Å:- Chain B: I.381, T.384, M.385, I.388, Y.389
- Chain C: W.535, A.538, V.539, L.542, Y.549, Q.553, D.565, Y.566, P.567, L.570
- Ligands: POV.24, POV.25, PCW.30
Ligand excluded by PLIPPOV.33: 15 residues within 4Å:- Chain C: P.464, L.468, T.471, F.496, Q.523, K.524, I.526, F.527, G.528, R.624
- Chain D: A.601, I.604
- Ligands: Y01.29, POV.31, POV.41
Ligand excluded by PLIPPOV.34: 14 residues within 4Å:- Chain C: F.383, C.386, C.387, L.413, Y.417, L.426, E.429, T.432, V.476, T.479, M.480, R.483, L.484, M.494
Ligand excluded by PLIPPOV.35: 4 residues within 4Å:- Chain C: F.474, V.478, V.481, M.482
Ligand excluded by PLIPPOV.36: 19 residues within 4Å:- Chain C: R.366, C.370, G.373, A.374, L.377, L.378, V.505, M.506, F.508, G.511, F.512, Q.513, M.514, L.515
- Chain D: W.535, L.536, V.539
- Ligands: PCW.44, POV.46
Ligand excluded by PLIPPOV.37: 11 residues within 4Å:- Chain C: L.378, C.382, M.385, Y.389, K.421, I.424, R.425, G.428
- Ligands: Y01.28, PCW.44, POV.46
Ligand excluded by PLIPPOV.38: 19 residues within 4Å:- Chain A: W.535, L.536, V.539
- Chain D: R.366, C.370, G.373, A.374, L.377, L.378, V.505, M.506, F.508, G.511, F.512, Q.513, M.514, L.515
- Ligands: PCW.3, POV.5
Ligand excluded by PLIPPOV.39: 11 residues within 4Å:- Chain D: L.378, C.382, M.385, Y.389, K.421, I.424, R.425, G.428
- Ligands: PCW.3, POV.5, Y01.42
Ligand excluded by PLIPPOV.41: 9 residues within 4Å:- Chain C: F.496, M.531
- Chain D: P.592, F.593, I.597
- Ligands: Y01.29, POV.31, POV.33, Y01.40
Ligand excluded by PLIPPOV.45: 7 residues within 4Å:- Chain D: M.475, V.478, M.482, S.488, V.492
- Ligands: POV.12, POV.47
Ligand excluded by PLIPPOV.46: 16 residues within 4Å:- Chain C: I.381, T.384, M.385, I.388, Y.389
- Chain D: W.535, L.542, Y.549, Q.553, D.565, Y.566, P.567, L.570
- Ligands: POV.36, POV.37, PCW.44
Ligand excluded by PLIPPOV.47: 14 residues within 4Å:- Chain A: I.604
- Chain D: P.464, L.468, T.471, F.496, Q.523, K.524, I.526, F.527, G.528, R.624
- Ligands: POV.12, Y01.43, POV.45
Ligand excluded by PLIPPOV.48: 15 residues within 4Å:- Chain D: F.383, C.386, C.387, L.413, Y.417, L.426, E.429, T.432, V.433, V.476, T.479, M.480, R.483, L.484, M.494
Ligand excluded by PLIPPOV.49: 4 residues within 4Å:- Chain D: F.474, V.478, V.481, M.482
Ligand excluded by PLIP- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structure-function analyses of human TRPV6 ancestral and derived haplotypes. Structure (2024)
- Release Date
- 2024-11-13
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 32 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structure-function analyses of human TRPV6 ancestral and derived haplotypes. Structure (2024)
- Release Date
- 2024-11-13
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.